These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors. Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery. Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230 [TBL] [Abstract][Full Text] [Related]
30. Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386 [TBL] [Abstract][Full Text] [Related]
31. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases. Ahmed KA; Freilich JM; Abuodeh Y; Figura N; Patel N; Sarangkasiri S; Chinnaiyan P; Yu HH; Etame AB; Rao NG J Neurooncol; 2014 May; 118(1):179-86. PubMed ID: 24604750 [TBL] [Abstract][Full Text] [Related]
32. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases. Eitz KA; Lo SS; Soliman H; Sahgal A; Theriault A; Pinkham MB; Foote MC; Song AJ; Shi W; Redmond KJ; Gui C; Kumar AMS; Machtay M; Meyer B; Combs SE JAMA Oncol; 2020 Dec; 6(12):1901-1909. PubMed ID: 33057566 [TBL] [Abstract][Full Text] [Related]
33. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure. Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270 [TBL] [Abstract][Full Text] [Related]
35. Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis. Wijetunga A; Jayamanne D; Cook R; Parkinson J; Little N; Curtis J; Brown C; Back M J Clin Neurosci; 2020 Dec; 82(Pt A):155-161. PubMed ID: 33317725 [TBL] [Abstract][Full Text] [Related]
36. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Wu SX; Chua DT; Deng ML; Zhao C; Li FY; Sham JS; Wang HY; Bao Y; Gao YH; Zeng ZF Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):761-9. PubMed ID: 17601682 [TBL] [Abstract][Full Text] [Related]
37. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy with a micro-multileaf collimator for brain metastasis in the primary motor cortex. Matsuda R; Hasegawa M; Tamamoto T; Ochi T; Miyasaka T; Inooka N; Hontsu S; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Nakase H J Radiat Res; 2022 Jan; 63(1):63-70. PubMed ID: 34927204 [TBL] [Abstract][Full Text] [Related]
38. Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases. Pessina F; Navarria P; Cozzi L; Ascolese AM; Maggi G; Riva M; Masci G; D'Agostino G; Finocchiaro G; Santoro A; Bello L; Scorsetti M PLoS One; 2016; 11(6):e0157869. PubMed ID: 27348860 [TBL] [Abstract][Full Text] [Related]
39. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034 [TBL] [Abstract][Full Text] [Related]
40. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases. Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]